A Moonshot for Cancer
GIAHC is honored to be a part of the Quad Cancer Moonshot team
Rising from WCC 2024: The Call to Eliminate Cervical Cancer and Our First Victory Over Cancer
The discussions at #WCC2024 ignited a powerful sense of hope and urgency. The path to eliminating #HPV and #cervicalcancer is clear, but it demands bold action—now. We are armed with the knowledge, technology, and tools to wipe out this preventable disease, which still claims a woman’s life every two minutes. If we do nothing, that number will rise to a woman every 90 seconds by 2050, unleashing untold devastation on families, communities, and nations alike.
We have no excuse to let this happen. The tools to end these unnecessary deaths are in our hands: #HPVvaccination, #screening, and #earlytreatment. These are not just medical interventions; they are weapons in a fight we can win.
The healthcare community has made strides, but that is not enough—we need a united public movement to finish this fight. The time is now to mobilize. We must arm people with the knowledge to demand the care they deserve: HPV vaccinations, self-screening for cervical cancer, and access to life-saving treatments. The HPV vaccine isn’t just a shield against cervical cancer—it prevents six different cancers across all genders. This is not a women’s issue—it’s a global fight that impacts us all.
We must also turn our focus to low- and middle-income countries, where the toll is highest. Equity in healthcare is non-negotiable. Technology and innovation are our keys to ensuring every woman, no matter where she lives, has the same chance to live free from this disease.
History has shown us the power of grassroots movements. The fight against HIV/AIDS was won through public activism, relentless awareness, and demand for care. Now, we must spark that same fire in the battle against HPV-related cancers—starting with cervical cancer.
Healthcare leaders, advocates, and the public must rise as one. Let this be our rallying cry: We will not wait. We will not lose more lives. We will make cervical cancer the first cancer we defeat.
Together, we can rewrite the future, eliminating cervical cancer and ensuring a healthier world for generations to come. The time for action is now—let’s claim our first victory over cancer.#GlobalCancerMoonshot
GIAHC joins President Biden’s Cancer Moonshot delegation to India (August 2024)
- AI enabled Innovation for Cancer Care
- Novel Therapeutics – Vaccines, Immunotherapy, and other Biologicals
- Cancer Genomics and Precision Medicine
- Cost Effective Equitable Cancer Therapy and Implementation Science
- Cancer Clinical Trials: Priorities, Regulatory Landscape& Capacity Building
- Holistic Survivorship Care
- Common Molecular links underlying Cancer, CVDs/NCDs –Role of Complementary & Alternative Medicines
GIAHC visits Capitol Hill and the White House with its youngest members
GIAHC is proud to share a report of its work with partners at PHRII , Mysuru India for International HPV Awareness Day.
GIAHC partners with Public Health Research Institute of India (PHRII) Mysore, to mark International HPV Awareness Day.
GIAHC is pleased to announce a report of its collaborative efforts with AMWA, UICC, and HealthyWomen
World Cancer Day 2024
GIAHC, in collaboration with the Public Health Research Institute (PHRII) at Mysuru, India, has been actively involved in raising awareness about HPV and cervical cancer elimination. Leading up to World Cancer Day, PHRII, with support from partners like JSS Academy of Higher Education and Research and sponsorship from Sun Pharma’s Corporate Social Responsibility wing, initiated a program to vaccinate 193 adolescent girls in rural Mysuru District against Human Papillomavirus (HPV), the primary cause of cervical cancer. This innovative initiative integrated vaccination with school-based community education, providing interactive sessions to schoolgirls, teachers, and parents on HPV, cervical cancer, and prevention. The girls were administered the Gardasil-9 vaccine, safeguarding them against nine high-risk HPV types. Aligned with the WHO’s Global Strategy for Cervical Cancer Elimination, the program aims for 90% vaccination coverage, 70% screening for women by ages 35 and 45, and 90% treatment for identified cervical disease by 2030. Cervical cancer, ranking as the second most common cancer in Indian women, remains a significant health challenge, underscoring the importance of initiatives like Mysuru’s in raising awareness and promoting vaccination and screening.
Photos: Courtesy of PHRII, Mysuru, India